Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A double-blind, randomized, placebo controlled, dose escalation, multi-center phase I/II trial of HuMax-CD20, a fully human monoclonal anti-CD20 antibody, in patients with active rheumatoid arthritis who have previously failed one or more disease modifying anti-rheumatic drugs https://kusajili.com:443/Trial/cmYS5uDYE0mzjZGONbhLQQ%24a-double-blind-randomized-placebo-controlled-dose-escalation-multi-center-phase-iii-trial-of-humax-cd20-a-fully-human-monoclona
I have read and accept the terms of use of the site and the Privacy Policy
Send your message